Trump Admin Claimed To Be Pro-Life, But Won't Regulate Mifepristone
4 Articles
4 Articles
Despite Promise To Be Pro-Life ‘Ally,’ Trump Admin Won’t Regulate Abortion Drug Endangering Women
The FDA appears to be slow-walking its mifepristone review, frustrating Trump allies in both Congress and pro-life states.
Democrats Could Win Midterms if Republicans Abandon Pro-Life Agenda
With midterm elections looming, the GOP has focused much attention on maintaining its razor-thin majority in the House of Representatives. While President Donald Trump and his allies have pushed for Republican-controlled states to aggressively redistrict and net the GOP extra House seats, a new survey is suggesting that the efforts may be for nought if the Trump administration and congressional Republicans don’t act decisively to regulate the re…
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium



